LGND: Nilai perusahaan marang bathi resik Ligand Pharma

Lambang korporat lan logo Ligand Pharmaceuticals Incorporated (LGND)

A steady stream of licensing payments and patent protection create significant defensive barriers for Ligand Pharmaceuticals (LGND). The company's P/E valuation clearly demonstrates the competition for promising molecules amid tight capital conditions, where the current status equals 121.30. Such a pragmatic approach to royalties ensures a professional brand image and mitigates investment risks.

LGND Ligand Corp: Koefisien rega marang bathi ing interval 04.07.2022 - 16.11.2026

Rincian metrik komprehensif lan analitis Ligand Pharmaceuticals Incorporated (LGND)

- rega lan prakiraan konsensus rega:
Analisis komprehensif perusahaan:Ligand Pharmaceuticals Incorporated - LGND
Barang unggulan Ligand

The P/E ratio reflects the market value of a single unit of net profit, allowing an investor to determine the investment payback period and the degree of asset overvaluation. By analyzing changes in the P/E value of Ligand Pharmaceuticals (LGND), one can assess the stability of Ligand Pharmaceuticals, whose royalty-based model minimizes operating expenses and makes cash flow more predictable compared to traditional pharmaceuticals.

Analisis perusahaan pesaing

HLN: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi KVUE (Kenvue Corp)|VRNA (Verona Pharma Inc.) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Jyong Biotech Limited MENS|Amneal (AMRX) - Kapitalisasi marang bathi|PRGO: Koefisien rega marang bathi|Alvotech SA - Rasio rega pasar marang bathi resik|LQDA: Pangali P/E|Galapagos Genomics - Nilai perusahaan marang bathi resik|ANIP (ANI Pharmaceuticals Inc) - Pangali P/E|Kapitalisasi marang bathi mannkindcorp.com MNKD|Rasio rega marang bathi Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX (Pacira Pharmaceuticals) - Nilai perusahaan marang bathi resik|Pangali P/E SPRY (ARS Pharmaceuticals Inc)|Rasio rega pasar marang bathi resik TBPH (Theravance)|AQST - Rasio rega marang bathi|scPharmaceuticals (SCPH) - Koefisien rega marang bathi|TECX: Pangali P/E|Pangali rega marang bathi TNXP|Rasio rega marang bathi China SXT Pharmaceuticals, Inc.|EPRX: Nilai perusahaan marang bathi resik|Pangali P/E BHST|EXOZ - Kapitalisasi marang bathi|Pangali P/E ORMP (oramed.com)|Pangali P/E enterabio.com ENTX|HYFT - Rasio rega marang bathi|Periode bali modal bisnis ABVC BioPharma, Inc ABVC|CPIX: Pangali P/E|Quantum BioPharma Ltd - Nilai perusahaan marang bathi resik|Koefisien rega marang bathi FGEN|Telomir Pharmaceuticals, Inc. - Kapitalisasi marang bathi resik|Pangali P/E RANI|SNYR (Synergy CHC) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Rallybio RLYB|Lexaria Bioscience (LEXX) - Kapitalisasi marang bathi|PULM - Rasio rega marang bathi|Periode bali modal bisnis Pheton Holdings PTHL|APM (Aptorum) - Koefisien rega marang bathi|Lyra Therapeutics, Inc. (LYRA) - Pangali P/E|IBO (impactbiomedinc.com) - Pangali P/E|TNFA (TNF Pharmaceuticals) - Rasio rega pasar marang bathi resik|Rasio rega marang bathi cbdmd.com (YCBD)|Periode bali modal bisnis PainReform Ltd|Pangali P/E CYTO (Altamira Therapeutics Ltd.)|Lipella Pharmaceuticals (LIPO) - Kapitalisasi marang bathi|OPTN - Rasio rega marang bathi|Pieris Pharmaceuticals - Rasio rega pasar marang bathi resik|PROC (Procaps Group) - Koefisien rega marang bathi|PTPI - Periode bali modal bisnis|Rasio rega marang bathi Qilian International Holding Group Limited|SLRN: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi TFFP (TFF Pharma)